Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Clinical trial NCT05465031 · RECRUITING

Trial details

NCT number: NCT05465031
Sponsor: Silesian Centre for Heart Diseases
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Cancer Neoplasm, Breast Breast Diseases Antihypertensive Agents Sacubitril/Valsartan Angiotensin II Type 1 Receptor Blockers Angiotensin Receptor Antagonists Molecular Mechanisms of Pharmacological Action Heart Failure Cardiac Toxicity Cancer, Therapy-Related Cancer Therapy-Related Cardiac Dysfunction

Start date: 2024-04-17
Primary completion: 2027-12-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.